GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.71 Cr | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.71 Cr |
| Mar2024 | ₹3.73 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹4.00 Cr |
| Mar2021 | ₹3.88 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.71 Cr | 26.36 | |
| Mar2024 | ₹3.73 Cr | -7.56 | |
| Mar2023 | ₹4.03 Cr | 0.98 | |
| Mar2022 | ₹4.00 Cr | 3.10 | |
| Mar2021 | ₹3.88 Cr | - | |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,397.5 Cr | -1.2% | -29.9% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -1.2% |
-29.9% |
-0.1% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses